Paternity following treatment for testicular cancer (Q40375677)

19 September 2017

Paternity following treatment for testicular cancer (English)

1 reference

19 September 2017

6

Tore Wentzel-Larsen

1 reference

19 September 2017

1

Marianne Brydøy

0 references

Olav Dahl

series ordinal

7

object named as

Olav Dahl

1 reference

19 September 2017

2

Sophie D Fosså

1 reference

19 September 2017

Olbjørn Klepp

3

1 reference

19 September 2017

Roy M Bremnes

series ordinal

4

1 reference

19 September 2017

Erik A Wist

series ordinal

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Journal of the National Cancer Institute

19 September 2017

1 reference

19 September 2017

97

1 reference

19 September 2017

21

1 reference

19 September 2017

1580-1588

1 reference

Fertility issues and their management in men with testis cancer

19 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Fertility after chemotherapy for testicular germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Sexual function after bilateral retroperitoneal lymph node dissection for nonseminomatous testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Paternity after irradiation for testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Combined management of malignant teratoma of the testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Non-paternity and prenatal genetic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

Estimating the frequency of nonpaternity in Switzerland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI339

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJI339

1 reference

19 September 2017

1 reference